BANK OF AMERICA CORP /DE/ - DIAMEDICA THERAPEUTICS INC ownership

DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 12 filers reported holding DIAMEDICA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of DIAMEDICA THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$6440
+1233.3%
0.00%
Q2 2022$030.0%0.00%
Q1 2022$030.0%0.00%
Q4 2021$0
-100.0%
3
-97.9%
0.00%
Q2 2021$1,0000.0%145
+113.2%
0.00%
Q1 2021$1,0000.0%68
-6.8%
0.00%
Q2 2020$1,00073
-65.4%
0.00%
Q3 2019$0
-100.0%
211
-96.4%
0.00%
Q4 2018$17,0005,9000.00%
Other shareholders
DIAMEDICA THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
JACOB ASSET MANAGEMENT OF NEW YORK LLC 233,730$369,2930.45%
COOPERMAN LEON G 812,508$1,283,8440.08%
CATALYST FINANCIAL PARTNERS LLC 14,475$22,8720.01%
Legend Financial Advisors, Inc. 1,000$1,5800.00%
GEODE CAPITAL MANAGEMENT, LLC 184,870$2920.00%
STATE STREET CORP 133,258$210,5480.00%
MORGAN STANLEY 55,201$87,2230.00%
BlackRock Inc. 69,937$110,5080.00%
Bank of New York Mellon Corp 36,062$56,9820.00%
Citadel Advisors 1,600$2,5280.00%
View complete list of DIAMEDICA THERAPEUTICS INC shareholders